ETF Building Blocks Channel Biotech ETF SBIO’s Momentum Strong to End 2023 By Nick Peters-GoldenDecember 28, 2023
ETF Building Blocks Channel Biotech ETF SBIO Sees Buy Signal Amid Hot Returns By Nick Peters-GoldenDecember 14, 2023
Energy Infrastructure Channel VettaFi Voices On: The Outlook for 2024 By Heather BellDecember 8, 2023
ETF Building Blocks Channel Play US Gene Treatment Approval in SBIO By Nick Peters-GoldenDecember 7, 2023
ETF Building Blocks Channel Innovation Could Propel Biotechnology Bounce By Todd ShriberOctober 31, 2023
ETF Building Blocks Channel 3 Growth-Minded ETFs to Play Fed Rate Pause By Nick Peters-GoldenJune 13, 2023
ETF Building Blocks Channel ALPS’ Biotech ETF SBIO Week’s Top Performer By Nick Peters-GoldenApril 24, 2023
ETF Building Blocks Channel Biotech ETFs’ Performance Deserves A Look By Nick Peters-GoldenApril 19, 2023
ETF Building Blocks Channel Biotech M&A Could Finally Be Ready to Rebound By Tom LydonFebruary 23, 2023
ETF Building Blocks Channel Gene Deal Adds New Dimension to Biotech ETF SBIO By Nick Peters-GoldenNovember 16, 2022
ETF Building Blocks Channel SBIO Rallied While Major Indexes Declined Last Week By Elle CarusoOctober 4, 2022
ETF Building Blocks Channel SBIO Outpaced XBI, IBB in Volatile Last Week By Elle CarusoSeptember 21, 2022
ETF Building Blocks Channel SBIO Was ALPS’ Top Performing ETF in August By Elle CarusoSeptember 1, 2022
Featured Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal By Max ChenAugust 5, 2022
Featured Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics By Max ChenAugust 4, 2022
